Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

ProShares Ultra Health Care

+ Add to Watchlist

RXL:US

147.4000 USD 1.1100 0.75%

As of 20:04:01 ET on 04/24/2015.

Snapshot for ProShares Ultra Health Care (RXL)

Open: 147.5100 High - Low: 148.8300 - 146.3800 Primary Exchange: NYSE Arca
Volume: 18,363 52-Week Range: 85.0020 - 151.9700 Beta vs DJUSHC: 1.6723

ETF Chart for RXL

No chart data available.
  • RXL:US 147.4000
  • 1D
  • 1M
  • 1Y
148.5100
Interactive RXL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RXL

Ultra Health Care ProShares is an exchange-traded fund incorporated in the USA. The Fund seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care Index.

Inception Date: 2007-02-01 Telephone: 1-240-497-6400
Managers: TODD BRUCE JOHNSON / HOWARD S RUBIN
Web Site: www.proshares.com

Fundamentals for RXL

NAV (on 2015-04-24) 147.2600
Assets (M) (on 2015-04-24) 231.9361
Shares out (M) 1.58
Market Cap (M) 232.15
% Premium 0.10
Average 52-Week % Premium 0.0251
Fund Leveraged Y
Fund Leverage Percent 200.0000 %

Dividends for RXL

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-25) 0.0705
Dividend Yield (ttm) 0.17%

Performance for RXL

1-Month +0.71% 1-Year +68.77%
3-Month +10.76% 3-Year +61.30%
Year To Date +19.04% 5-Year +42.35%
Expense Ratio 0.95

Top Fund Holdings for RXL

Filing Date: 09/30/2014
Name Position Value % of Total
Johnson & Johnson 90,055 9,598,962 11.508%
Pfizer Inc 202,472 5,987,097 7.178%
Merck & Co Inc 92,110 5,460,281 6.546%
Gilead Sciences Inc 48,270 5,138,342 6.160%
Amgen Inc 24,255 3,406,857 4.084%
AbbVie Inc 50,825 2,935,652 3.519%
Bristol-Myers Squibb Co 52,939 2,709,418 3.248%
UnitedHealth Group Inc 31,025 2,675,906 3.208%
Biogen Inc 7,540 2,494,307 2.990%
Celgene Corp 25,529 2,419,639 2.901%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil